Alentis Therapeutics reposted this
Congratulations to Dr. Delbet for his great presentation "Novel therapeutic for crescentic glomerulonephritis through targeting CLDN1 in parietal epithelial cells" awarded as Top 10 Abstracts at #ERA24. Thank you Pierre-Louis Tharaux and Olivia Lenoir for this great Collaboration with Alentis Therapeutics. Proud and happy to be part of it.